TrialArteriosclerosis, thrombosis, and vascular biology2024

Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial.

Michael A Pfeffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.